Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation.
Thiemermann
Christoph
C
Department of Experimental Medicine and Nephrology, William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London EC1M6BQ, UK. c.thiemermann@mds.qmw.ac.uk
D000818:Animals; D002463:Cell Membrane Permeability / Q000187:drug effects*; D003497:Cyclic N-Oxides / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004195:Disease Models, Animal; D016166:Free Radical Scavengers / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D008297:Male; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy*; D012769:Shock / Q000188:drug therapy*; D013113:Spin Labels
D003497:Cyclic N-Oxides; D016166:Free Radical Scavengers; D013113:Spin Labels; C001803:tempol